Moreover, further expression analyses suggested a downregulation of CKMT2-AS1, SGMS1-AS1, and SNHG14 (Figure 10G, all p < 0.05) in bladder cancer. The gene discussed is CKMT2; the disease is urinary bladder carcinoma.